Low-Dose Naltrexone: An Inexpensive Medicine for Many Ills? (Abstract)

The LDN Conference 2021: 4th - 6th June 2021

Up to 29 CME Credits Available + Sponsor, Exhibitor and Advertiser Opportunities.  [More Details]

Low-Dose Naltrexone: An Inexpensive Medicine for Many Ills?

Medscape Medical News
11 Mar 2020
https://www.medscape.com/viewarticle/926611?src=WNL_trdalrt_201027_MSCPEDIT&uac=267476HJ&impID=2640101&f

·        Summary: low dose naltrexone at low doses can operate as an anti-inflammatory agent in the central nervous system. There is accumulating data from different sources showing that low dose naltrexone has the ability to relieve pain and other symptoms of various chronic inflammatory conditions.

Several studies have been conducted and published, acknowledging the use of low dose naltrexone. One three-patient series published in BMJ Case Reports has shown the successful use of LDN in relieving pain, fatigue, and cognitive function in patients with myalgic encephalomyelitis/chronic fatigue syndrome. A series of articles were established in Norway, reporting the impact of a surge in low dose naltrexone prescribing in the country since 2013. A UK physician who contracted meningitis and soon developed ME/CFS presented herself as case number 1 in the BMJ Case Reports. She began taking LDN in 2010 at a starting dose of 1.5 mg/day and has recovered to the point of near-normal health.

Summary by  Erin Williams, student, St. Louis College of Pharmacy